Loading…
← CockpitCompetitor Analysis › OPT.L Optima Health PLCOpen in the cockpit ↗

Optima Health PLCOPT.LCompetitor analysis, valuation and peers

United Kingdom · GBP·Industrials›Miscellaneous Commercial Services
Momentum strong 78
Mkt cap
$349M
US dollars, full cap
Free float
72%
of shares outstanding
$/day
$182,184
20-day average traded
Fwd P/E
18.6×
forward earnings
ROIC−WACC
-5.3 pp
WACC 6.6%
Hurdle
+28 pp
Req g minus delivered
Next earnings
28 days
16 Dec 2026
Close · GBP£244.00
1D-0.4%
1W-0.4%
1M0.0%
3M+2.5%
6M+29.4%
YTD+22.0%
1Y+21.1%
ATR %1.8%
52w lowhigh7.6% off high

What Optima Health does

No business profile yet.

Optima Health at a glance

Size Optima Health (OPT.L) is a United Kingdom Industrials company (Miscellaneous Commercial Services) with a market value of $349M, the 336th largest of 355 United Kingdom companies the cockpit tracks. Shares closed at £244.00 on 18 Nov 2026.

Performance Over six months the shares gained 29.4%, against -21.0% for the median peer and +0.1% for the United Kingdom market (cap-weighted) — 2nd highest of 21 in its peer set.

Growth Revenue grew 14.8% over the last twelve months (peer median +4.2%); the operating margin is 3.3% (peer median 6.5%).

Valuation It trades at 18.6× forward earnings against a peer median of 18.6× (6th cheapest of 11).

Price implies For today's price to make sense, revenue must grow about 30% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is +28 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 5.3 points below its cost of capital (6.6% WACC).

Next results Next results expected around 16 Dec 2026 (exchange calendar; dates can move).

Relative performance

8010012014021 May 202621 Aug 202618 Nov 2026OPT.L 130Peer median 78
Six months, rebased to 100: Optima Health against the median of its 20 peers (local-currency closes).

Optima Health financials

Reported figures in GBP; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue£121M£121M£105M£111M£115M
Revenue growth—+15%-5%-4%—
Gross profit£28.6M£28.6M£26.7M£25.7M£26.7M
EBITDA£15.2M£15.2M£17.6M£18.2M£20.8M
Net income£1.40M£1.40M£1.65M-£1.08M£1.59M
Free cash flow£13.2M£13.2M£451,000£12.4M£4.86M
Capital expenditure£3.13M£3.13M£3.75M£2.85M£4.20M
Total debtn/a£95.0M£21.7M£2.40M£3.77M

Quarterly statements and history in the cockpit →

Optima Health competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%-10%0%+10%4480792135879658HSP3009770028870752002659ACRRTNINDIA301257MZH174900KBL002861SEILAVCT6088002663OPT.L6-month return →1-month return →
Up and to the right = strong over both horizons. Optima Health is the large dot.

Fundamentals: revenue growth against valuation

0%+20%50×100×44803587HSP300977002887002659301257MZHKBL6088OPT.LRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Optima Health is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%4480792135879658HSP300977002887002659MZHKBL6088OPT.LGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Optima Health is the large dot.

Optima Health competitors and peer comparison

How Optima Health compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Optima Health against its 20 peers (data as of 18 Nov 2026)
MeasureOPT.LPeer medianRank in peer set
1-month return0.0%-3.5%8th highest of 21
6-month return+29.4%-21.0%2nd highest of 21
Distance from 52-week high-7.6%-41.6%3rd highest of 21
Revenue growth (TTM)+14.8%+4.2%6th highest of 21
Operating margin3.3%6.5%8th lowest of 20
Forward P/E18.6×18.6×6th cheapest of 11
Growth the price implies (Req g, 7 yrs)29.8%3.9%2nd most demanding of 12
Growth delivered (Del g)+1.5%+7.6%4th lowest of 12
Hurdle (Req g minus delivered)+28.3 pp-7.1 pp2nd most demanding of 12
ROIC minus cost of capital-5.3 pp-4.2 pp9th lowest of 20
EV / EBITDA22.3×7.4×most expensive of 10
Net debt / EBITDA4.8×0.2×2nd most indebted of 12

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Optima Health OPT.LUnited Kingdom$349M+29%+15%3%18.6×29.8%+1.5%
Medley 4480.TJapan$349M-16%+21%7%21.7×13.0%+40.0%
Takara & 7921.TJapan$350M+27%+4%15%n/a-11.7%+4.7%
Materials Analysis Technology 3587.TWOTaiwan$350M-53%+4%14%11.4×0.9%+12.6%
Business Brain Showaota 9658.TJapan$344M+63%+5%7%n/a0.5%+7.6%
Hargreaves Services HSP.LUnited Kingdom$355M+10%+33%4%17.9×9.4%+11.4%
Shenzhen Ridge Technology 300977.SZChina$342M-31%+20%-3%31.2×42.0%-4.0%
Tianjin LVYIN Landscape & Ecology Construction 002887.SZChina$341M-48%-8%12%16.2×10.6%-13.0%
Pico Far East 0752.HKHong Kong$341M-10%+3%6%n/an/an/a
Beijing Kaiwen Education Technology 002659.SZChina$357M-19%+7%8%113.7×15.1%+1.5%
Axactor ACR.OLNorway$340M-19%-146%n/an/an/an/a
RattanIndia Enterprises RTNINDIA.NSIndia$359M-28%-3%1%n/an/an/a
SMO ClinPlus 301257.SZChina$359M-35%0%3%19.2×n/an/a
Nanofilm Technologies International MZH.SISingapore$339M-50%+10%8%21.6×3.9%+2.3%
AbClon 174900.KSSouth Korea$360M-40%+45%-337%n/an/an/a
K-Bro Linen KBL.TOCanada$361M-1%+31%8%14.4×3.3%+20.9%
YingTong Telecommunication 002861.SZChina$362M-23%+15%-8%n/an/an/a
Shanti Educational Initiatives SEIL.NSIndia$335M-1%-18%4%n/an/an/a
Avacta AVCT.LUnited Kingdom$363M-33%-100%-27,388%n/an/an/a
SIGMAXYZ 6088.TJapan$334M+9%-13%24%11.6×-8.1%+11.2%
Pubang Landscape Architecture 002663.SZChina$364M-36%-25%-24%n/an/an/a

Questions

Which companies are Optima Health's closest peers?
The cockpit's peer set: Medley (4480.T), Takara & (7921.T), Materials Analysis Technology (3587.TWO), Business Brain Showaota (9658.T), Hargreaves Services (HSP.L), Shenzhen Ridge Technology (300977.SZ), Tianjin LVYIN Landscape & Ecology Construction (002887.SZ), Pico Far East (0752.HK).
Is Optima Health expensive compared with its peers?
On forward p/e it trades at 18.6× against a peer median of 18.6×, 6th cheapest of 11 in its peer set. For today's price to make sense, revenue must grow about 30% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is +28 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Optima Health stock performed?
Over six months to 18 Nov 2026 the shares returned +29.4% against -21.0% for the median peer; over one year +21.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.